Edwardsiella tarda infections in humans: a systematic review of reported cases and clinical outcomes
Abstract
Background: Edwardsiella tarda, a rare human pathogen in the Enterobacteriaceae family, primarily inhabits aquatic environments and infects various animals. Human infections are uncommon but can lead to severe clinical outcomes. This systematic review aims to consolidate and analyze reported human cases of E. tarda infection.
Methods: A comprehensive search was conducted across PubMed, Scopus, Embase, and Web of Science databases for studies published between January 2000 and October 2025.
Results: After applying exclusion criteria, 59 unique case reports were included. Cases spanned both genders, predominantly affecting older adults, with Japan reporting the highest number. A history of seafood consumption or contact with aquatic animals was common. Clinical presentations varied, though fever and abdominal pain were most frequent. Laboratory findings typically revealed elevated C-reactive protein and leukocytosis. Treatment regimens included antibiotics such as meropenem, ceftriaxone, ampicillin, metronidazole, and levofloxacin, the most frequently used.
Conclusions: Despite its rarity, E. tarda can cause life-threatening infections. Awareness among clinicians regarding risk factors, diagnostic methods-particularly culture-based identification-and timely antibiotic therapy is crucial for improved outcomes.
Clinical trial number: Not applicable.
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.